Large Cap Biotech Analyst Fye holds a conference call with President & CEO Torley on June 7 at 11 am hosted by JPMorgan.Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HALO:
- Halozyme Raises Full Year 2024 Financial Guidance and Updates 5-Year Financial Outlook
- Halozyme raises FY24 non-GAAP EPS view to $3.65-$4.05 from $3.55-$3.90
- Halozyme granted European patent covering ENHANZE drug delivery platform
- Halozyme and Bristol Myers’ combination receives updated FDA action date
- Halozyme price target raised to $45 from $39 at Leerink
Questions or Comments about the article? Write to editor@tipranks.com